Drug Scientists Slow to Adopt Open Source

By M.L. Baker  |  Posted 09-08-2005
Print this article   Print this article
A surge in open-source technology has given many businesses more options for powerful, low-cost software. But the pharmaceutical industry remains well behind the curve.
CIO
INSIGHT
POLL
CIO
INSIGHT
VIDEO
  • The Role of Standards in Cloud Security

    Security is often cited as a primary cause for concern...

    Watch Now
  • Ensuring Resources for Mission Critical Workloads

    Application workloads can thrive in cloud environments,...

    Watch Now
  • Improving Security in the Public Cloud

    One of the main concerns about moving data to a public...

    Watch Now